Physical Therapy in the United States: Declaration of Change of Beneficial Ownership (Form 4)

0






Property Submission

FORM 4

Check this box if you are no longer subject to section 16, the obligations of Form 4 or Form 5 may continue. To see Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN THE EFFECTIVE BENEFICIARIES OF THE SHARES Filed under Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number: 3235-0287 Expires: January 31, 2005 Estimated average charge hours per response…0.5

1. Name and address of reporting person *

CHRISTOPHER J READING

2. Name of issuer and stock symbol or trading symbol
US PHYSICAL THERAPY INC / NV [USPH]

5. Relationship between the reporting person(s) and the issuer
(Check all that apply)

__X__ Director

_____ 10% Owner

_____ Officer (indicate title below)

_____ Other (specify below)

Chief Executive Officer /

(Last)

(First)

(Environment)

1300 W. SAM HOUSTON PKWY S., SUITE 300

3. Date of first transaction (month/day/year)

(Street)

HOUSTON

TX

77042

4. In case of modification, date of filing of the original (month/day/year)

6. Individual or joint/group filing (check applicable row)
_X_ Form filed by a reporting person
___ Form filed by more than one declarant

Table I – Non-derivative securities acquired, sold or beneficially owned

1. Title of guarantee

2. Transaction date (month/day/year)

2A. Deemed execution date, if applicable (month/day/year)

3. Transaction code

4. Securities acquired (A) or transferred (D)

5. Amount of securities beneficially owned as a result of the reported transaction(s)

6. Form of ownership: direct (D) or indirect (I)

7. Nature of Indirect Beneficial Ownership

Coded

V

Rising

(A) or (D)

Price

Table II – Beneficial ownership derivative securities (for exampleputs, calls, warrants, options, convertible securities)
(for exampleputs, calls, warrants, options, convertible securities)

1. Title of derivative title

2. Conversion or exercise price of the derivative security

3. Transaction date (month/day/year)

3A. Deemed execution date, if applicable (month/day/year)

4. Transaction code

5. Number of derivative securities acquired (A) or sold (D)

6. Exercise date and expiry date

7. Title and amount of the securities underlying the derivative securities

8. Price of derivative securities

9. Number of derivative securities beneficially owned as a result of reported transactions

10. Form of ownership of derivative securities: direct (D) or indirect (I)

11. Nature of Indirect Beneficial Ownership

Coded

V

(A)

(D)

Exercise date

Expiration date

Title

Amount or number of shares

Reporting owners

Name/address of declaring owner Relationships

Director

10% Owner

Officer

Other

CHRISTOPHER J READING
1300 W. SAM HOUSTON PKWY S.
SUITE 300
HOUSTON, TX77042

X

Chief Executive Officer

Signatures

Christophe J Reading

2022-03-15

**Signature of declaring person

Dated

Explanation of answers:

If the form is completed by several declarants, to see

Section 5(b)(v).

(**) Intentional misrepresentation or omission of facts are federal criminal offenses. To see

18 USC 1001 and 15 USC 78ff(a).

(1)

The 20,000 common shares were granted as restricted stock pursuant to the Company’s Amended and Restated 2003 Stock Incentive Plan. The restrictions expire in 16 equal quarterly installments with the first 1,250 shares on April 1, 2022 and the last 1,250 shares expiring on January 1, 2026, if employed by the Company on those dates.

(2)

Includes the 20,000 shares in footnote 1 and includes 20,711 shares whose restrictions expire at 2,876 on April 1, July 1 and October 1, 2022; 2,879 shares as of January 1, 2023; 1,598 shares on each of April 1, July 1 and October 1, 2023; 1,610 shares as of January 1, 2024; and 700 shares on each of April 1, July 1 and October 1, 2023 and January 1, 2025, if he is an employee of the Company on these dates. Note: Submit three copies of this form, one of which must be manually signed. If space is insufficient, To see

Instruction 6 for the procedure. Potential individuals who need to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.

Warning USPh – US Physiotherapy Inc. published this content on March 15, 2022 and is solely responsible for the information contained therein. Distributed bypublic unedited and unmodified, onMarch 15, 2022 14:01:04 UTC

.

Public now 2022

All news about US PHYSICAL THERAPY, INC.

Analyst Recommendations for US PHYSICAL THERAPY, INC.

2022 sales
554M
2022 net income
43.0 million
Net debt 2022

PER 2022 ratio
28.2x 2022 return
Capitalization
1,208 million
1,208 million
capi. / Sales 2022
2.18x capi. / Sales 2023
2.06x # of employees
4,250 Floating

Chart US PHYSICAL THERAPY, INC.









US Physical Therapy, Inc. Technical Analysis Chart |  MarketScreener

US Physical Therapy, Inc. Technical Analysis Chart | MarketScreener

US PHYSICAL THERAPY, INC. Technical Analysis Trends
Short term Middle term
Long term Tendencies Neutral Neutral

Bearish


Please enable JavaScript in your browser settings to use dynamic graphics.

To sell

To buy Medium consensus
TO BUY Number of analysts
5

Last closing price

$93.25

Average target price

$126.75 Average Spread / Target

Please enable JavaScript in your browser settings to use dynamic graphics.


Share.

Comments are closed.